Argosy Healthcare Partners Recapitalizes and Merges Hudson Robotics and Art Robbins Instruments

July 12, 2022

Argosy Healthcare Partners completed a recapitalization and merger of Hudson Robotics and Art Robbins Instruments to form a unified life‑sciences tools platform. The firm is backing Andrew Witschi as CEO and plans to invest in commercialization, product development and software (SoftLinx) to accelerate growth across biopharma, pharma and academic end markets.

Buyers
Argosy Healthcare Partners
Targets
Hudson Robotics, Art Robbins Instruments
Industry
Medical Devices
Location
United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.